Diffuse Lung Disease
-
Psilocybin-assisted therapy bests nicotine patch for smoking cessation in pilot study
At six months following the target quit date, 40.5% of participants in the psilocybin group achieved biochemically verified prolonged abstinence compared with only 10.0% in the nicotine patch group.
-
When oil infrastructure burns: What pulmonary clinicians should know
Recent conflict in the Middle East sheds light on oil fires as respiratory exposure events. Pulmonary clinicians need to be prepared to treat both acute and chronic symptoms from these exposures.
-
Phase 3 TETON trials demonstrate positive results for inhaled treprostinil for IPF
Steven D. Nathan, MD, FCCP, said the evidence shows the drug is effective for treating pulmonary hypertension and may slow or prevent fibrosis progression.
-
Data show oral nalbuphine significantly reduces chronic cough in idiopathic pulmonary fibrosis
Experts discuss the promising results—particularly surrounding patient-reported outcomes in this population—and the need for long-term safety data.
-
Airway complications post-lung transplant: Risk factors, outcomes, and interventions
Early detection and phenotype-driven bronchoscopic management are key to improving outcomes in patients with airway complications after undergoing lung transplantation.
-
Study links nocturnal GERD, undiagnosed OSA to worse outcomes in IPF
Researchers said the findings support evaluation of sleep‑related comorbidities to identify potentially modifiable contributors to symptoms and physiologic impairment.
-
Local and state options for clean air and climate advocacy
Health care professionals can help drive practical, equitable clean air solutions that protect patients by leveraging their expertise in the clinic, community, and policy arena.
-
Bilateral lung transplant comparable to heart-lung transplant in primary PAH
Recent findings reinforce the widely used strategy of bilateral lung transplantation for most patients with primary PAH who do not have structural heart disease.
-
Black lung disease mortality on the rise, recent analysis shows
CDC experts David N. Weissman, MD, FCCP, and Jacek Mazurek, MD, PhD, said that identifying dust exposure is key to improving outcomes for patients with coal workers’ pneumoconiosis.
-
Text-message program may aid smoking cessation in patients with TB
A recent trial highlights the impact of a mobile health-based initiative to aid in smoking cessation within TB treatment programs, said author Maham Zahid, PhD.
-
Optimal synergy: Coupling smart wearable devices, sensors with AI algorithms
Coupling noninvasive wearable devices with AI-enabled data analytics helps to address two key challenges: health care access and improvement of patient-centric care.
-
Bridging the gap: Mechanical circulatory support in lung transplantation for PAH
Review the need for ECLS, MCS, and ECMO in patients with PAH who are undergoing lung transplantation.
